ABOLOGIX

abologix-logo

ABOLOGIX is developing best-in-class monoclonal antibodies by blocking the Junction Adhesion Molecule JAM-C and the extracellular matrix-related protein. The treatment is designed for patients that do not respond to traditional cancer therapies.

#SimilarOrganizations #People #Financial #Website #More

ABOLOGIX

Industry:
Biotechnology Medical Therapeutics

Founded:
2018-02-02

Address:
Plan-les-ouates, Geneve, Switzerland

Country:
Switzerland

Website Url:
http://www.abologix.com

Total Employee:
1+

Status:
Active

Contact:
+ 41 (022) 8801010

Email Addresses:
[email protected]

Total Funding:
160 K CHF

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google GStatic Google Static Content Google Cloud Wix


Similar Organizations

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

theolytics-logo

Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.

Current Employees Featured

thomas-matthes_image

Thomas Matthes
Thomas Matthes Co-founder @ Abologix
Co-founder

ignacio-faus_image

Ignacio Faus
Ignacio Faus Co- founder and Chairman @ Abologix
Co- founder and Chairman
2018-01-01

beat-imhof_image

Beat Imhof
Beat Imhof Co-founder @ Abologix
Co-founder

Founder


beat-imhof_image

Beat Imhof

ignacio-faus_image

Ignacio Faus

thomas-matthes_image

Thomas Matthes

Investors List

venturekick_image

Venture Kick

Venture Kick investment in Debt Financing - Abologix

venturekick_image

Venture Kick

Venture Kick investment in Grant - Abologix

Official Site Inspections

http://www.abologix.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Abologix"

Abologix - Crunchbase Company Profile & Funding

Organization. Abologix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... ABOLOGIX is โ€ฆSee details»

Abologix - Overview, News & Similar companies | ZoomInfo.com

Abologix contact info: Phone number: +41 228801010 Website: www.abologix.com What does Abologix do? ABOLOGIX is a biopharmaceutical company based in Geneva, Switzerland. It is โ€ฆSee details»

Abologix Sàrl - Swiss Biotech

Abologix is a biopharmaceutical company and a spin-out from the laboratories of Prof. Beat Imhof and Prof. Thomas Matthes at the University of Geneva. ... Additional address info. c/o Fongit ; Canton. Geneva; Facts & figures. Type of โ€ฆSee details»

Abologix Company Profile 2024: Valuation, Funding & Investors

Abologix General Information Description. Operator of a biopharmaceutical company intended to develop novel therapeutics designed for oncology treatment. The company offers a โ€ฆSee details»

ABOLOGIX - Products, Competitors, Financials, Employees, โ€ฆ

Abologixโ€™s therapeutic option includes a monoclonal antibody, code-named H225, that blocks JAM-C. Learn more about Ignacioโ€™s expectations for the Venture Leader Biotech experience โ€ฆSee details»

ABOLOGIX Sàrl Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ABOLOGIX Sàrl of Plan-les-Ouates, GENÈVE. Get the latest business insights from Dun & Bradstreet.See details»

ABOLOGIX - VentureRadar

ABOLOGIX is developing best-in-class monoclonal antibodies by blocking the Junction Adhesion Molecule JAM-C and the extracellular matrix-related protein Olfactomedin-like protein 3 โ€ฆSee details»

Abologix - Org Chart, Teams, Culture & Jobs - The Org

View Abologix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»

Abologix - Developing Best-In-Class Monoclonal Antibodies โ€ฆ

Abologix is a biopharmaceutical company based in Geneva, Switzerland. The company is a spin out from the laboratories of Prof. Beat Imhof and Thomas Matthes at the University of Geneva โ€ฆSee details»

Abologix - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Abologix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Abologix has 3 โ€ฆSee details»

Abologix - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 26, 2021: Debt Financing โ€ฆSee details»

Abologix Sàrl - Drug pipelines, Patents, Clinical trials - Synapse

Explore Abologix Sàrl with its drug pipeline, therapeutic area, technology platform, , Technology Platform:Monoclonal antibody, Drug:SrpX2 mAB (Abologix). Biomedical products. ... The โ€ฆSee details»

Abologix Sàrl - Venture Kick

May 27, 2021 Abologix Sàrl: ABOLOGIX develops novel therapeutics in oncology. The company´s lead program is a monoclonal antibody (code-named H-225) for the treatment of โ€ฆSee details»

Nextsource | Company Profile | Abologix

Find out if Abologix is undergoing leadership changes or executive team restructuring. Learn about mergers or acquisitions involving Abologix . Track key 'champions' at Abologix as they โ€ฆSee details»

ABOLOGIX founded in Geneva, Switzerland

Geneva, Switzerland, January 25, 2018.Abologix was launched today, and it is the newest addition to the biotechnology ecosystem in the city of Geneva (Switzerland). The three โ€ฆSee details»

ABOLOGIX - Company Profile - Tracxn

Oct 22, 2024 ABOLOGIX ranks 1,155th among 2411 active competitors. 871 of its competitors are funded while 548 have exited. Overall, ABOLOGIX and its competitors have raised over โ€ฆSee details»

Scams Details - Better Business Bureau

Apr 23, 2024 Abologix. Date Reported. April 23, 2024. Scam ID. 835204. Similar to your experience? If you find a scam ID that matches your experience, tell us what happened and โ€ฆSee details»

News | Abologix

Nov 1, 2020 Abologix has been granted a 2 year Innosuisse Innovation project in collaboration with the University Hospital of Geneva (HUG). The HUG will be the research partner and โ€ฆSee details»

Abologix Reviews | Read Client Reviews of Abologix. - trustburn.com

Read reviews of Abologix. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. Search. Abologix โ€ฆSee details»

linkstock.net © 2022. All rights reserved